Machine Learning to Predict In-Hospital Cardiac Arrest in Patients Admitted from the Emergency Department with COVID-19 and Suspected Pneumonia
Summary | There are only scarce models developed for stratifying the risk of cardiac arrest from COVID-19 patients presenting to the ED with suspected pneumonia. By using the machine learning (ML) approach, we aimed to develop and validate the ML models to predict in-hospital cardiac arrest (IHCA) in patients admitted from the ED. Hypothesis: We hypothesized that ML approach can serve as a valuable tool in identifying patients at risk of IHCA in a timely fashion. Methods: We included the COVID-19 patients admitted from the EDs of five hospitals in Texas between March and November 2020. All adult (≥ 18 years) patients were included if they had positive RT-PCR for SARS-CoV-2 and also received CXR examination for suspected pneumonia. Patients' demographic, past medical history, vital signs at ED triage, CXR findings, and laboratory results were retrieved from the EMR system. The primary outcome (IHCA) was identified via a resuscitation code. Patients presented as OHCA or without any blood testing were excluded. Nonrandom splitting strategy based on different location was used to divide the dataset into the training (one urban and two suburban hospitals) and testing cohort (one urban and one suburban hospital) at around 2-to-1 ratio. Three supervised ML models were trained and performances were evaluated and compared with the National Early Warning Score (NEWS) by the area under the receiver operating characteristic curve (AUC). Results: We included 1,485 records for analysis. Of them, 190 (12.8%) developed IHCA. Of the constructed ML models, Random Forest outperformed the others with the best AUC result (0.930, 95% CI: 0.896-0.958), followed by Gradient Boosting (0.929, 95% CI: 0.891-0.959) and Extra Trees classifier (0.909, 95% CI: 0.875-0.943). All constructed ML models performed significantly better than by using the NEWS scoring system (AUC: 0.787, 95% CI: 0.725-0.840). The top six important features selected were age, oxygen saturation at triage, and lab data of APTT, lactic acid, and LDH. Conclusions: The ML approach showed excellent discriminatory performance to identify IHCA for patients with COVID-19 and suspected pneumonia. It has the potential to save more life or provide end-of-life decision making if successfully implemented in the EMR system. | ||
---|---|---|---|
Keyword | COVID-19 machine learning cardiac arrest | ||
Research Project | The application of smart band monitoring to construct a risk predictionalarm model for patients visiting the emergency department | ||
Research Team | Co-PI: National Taiwan University, Dr. Tsung-Chien Lu |
More like this
Provide the latest information of AI research centers and applied industries
-
Integration of an ICU Visualization Dashboard (i-Dashboard) as a Platform to Facilitate Multidisciplinary Rounds
Multidisciplinary rounds (MDRs) are scheduled, patient-focused communication mechanisms among multidisciplinary providers in the intensive care unit (ICU). The surgical ICU team of National Cheng Kung University Hospital has developed and integrated i-Dashboard as a platform to facilitate MDRs. i-Dashboard is a custom-developed visualization dashboard that supports (1) key information retrieval and reorganization, (2) time-series data, and (3) display on large touchscreens during MDRs. The i-Dashboard increases the efficiency in data gathering and enhances communication accuracy and information exchange in MDRs.
-
Cardiovascular Health Guardian – Novel Pulse Wave Velocity and Personal Blood Pressure Estimation System for Smart Watch
Our team develops an accurate PWV estimation algorithm that uses wrist PPG and ECG signals from wearable devices. A missing-feature imputation and ambiguous-feature resolution technique is developed and the availability of wrist PPG morphological features is raised from 60% to 99.1%. A weighted pulse decomposition approach is adopted and 5 component waves can be acquired to examine more detailed properties. The PWV is then estimated by XGBoost algorithm with the hierarchical regression model.
-
HeaortaNet (Automatic Pericardium/Aorta Segmentation AI Model [HeaortaNet])
The Pericardium/Aorta Segmentation and Cardiovascular Risk Prediction AI Total Solution Model, HeaortaNet, is a deep learning model based on UNet and attention gate, and had been trained by >70,000 axial images with verified annotations of the pericardium and aorta. It shortens the time for data processing from 60 minutes, by manual segmentation of both pericardium and aorta, to 0.4 seconds. The segmentation accuracy is 94.8% for the pericardium, and 91.6% for the aorta. The applicability of HeaortaNet had been demonstrated by analyzing the non-contrast chest CT scans (>5,000 cases) deposited in the mega-image bank of National Health Insurance Databank.
-
iSleepBetter Corporation
Intelligent Portable Neurofeedback Training System: Highlights of our product: 1. High accurate EEG value (with rigorous hardware and software design and verification) 2. real-time feedback by computer screen or APP 3. can be used at home (easy to ware, easy to use)
-
DeepFIND
Artificial Intelligence Automatic Sputum Microscopy System AIASMS: AIASMS can automatically shoot images from sputum smear samples and identify Mycobacterium tuberculosis(MTB). AIASMS can find the most suitable depth for shooting images and then automatically shoot images under the microscope through auto-focusing. These images will be stored in the cloud database. Meanwhile, AIASMS detect whether the sputum smear contains MTB. AIASMS can accurately label the location of the TB. The sensitivity and specificity can reach 90% and 99% respectively. We also cooperate with three hospitals in the northern, central, and southern regions of Taiwan to conduct blind testing, and the sensitivity can be more than 90%. AIASMS can also distinguish between MTB and Non-tuberculous mycobacteria (NTM). Finally, n the expansion of technology, we have extended the identification of the acid-resistant staining to the identification of gram staining, so that our system can widely identify a variety of bacteria.
-
ALOVAS
ALOVAS Platform: ALOVAS acts as an A.I. Pathology Platform which provides high resolution pathology image viewer. Even Giga-pixel-level original images can be viewed online in real time. ALOVAS platform can be used not only on computer, but also on iPad. Users can upload images on the platform and select AI models for automated detection, and browse the detection results on the platform. ALOVAS also provides commonly used annotation tools, including hand-drawing, dots, rectangles, etc., which can be used to mark areas of interest. Embedded with the ALOVAS platform also provided several detection algorithms. We hope ALOVAS can assist physicians in rapid diagnosis, in related pathological research, and reduce the workload of pathologists in the future.
-
alpha pulse
ECG STEMI AI Model: In the past, most AI systems gave people the feeling of a black box and couldn't be trusted. The team designed a mechanism that allows doctors to adjust and observe the AI model, so that the AI model can be customized to the functions the doctor wants. We use LINE, the most commonly used communication software for doctors, to design an EKG Line Bot. Medical staff can upload an electrocardiogram to the EKG Line Bot to instantly identify whether the electrocardiogram is Stemi, so as to help doctors determine whether the patient has signs of myocardial infarction. We use this Line Bot to cooperate with doctors and ask them to communicate with the Line Bot. According to the heat map provided by the system, we can check whether it is consistent with the medical concept, and then help us correct the accuracy of our model. The system will train the correct data again.
-
NTU CSIE Medical Informatics Lab
NTU Medical Genie Precision Health Platform: The product is mainly composed of wearable devices, IoT environmental sensors, deep learning, personal health app and case management platform. It can collect and monitor user's lifestyle and environment automatically, and predict the possibility of emergency to assist medical staff in making decisions. In addition, we opened source the project to solve most clinical studies that require lots of time to build data collection tools and processes.
-
Digital Medicine Center of National Yang Ming Chiao Tung University
AI-based Brain Assessment System: Mental illness is a critical health issue in Taiwan. Psychiatric diagnosis is largely based on self-reported or symptomatic criteria without objective findings. This state-of-the-art psychiatric diagnostic platform using standardized brain imaging data, however, improves the efficiency and accuracy of psychiatric diagnosis. Our platform can easily identify the deficiency in brain regions associated with schizophrenia, provides a novel way to evaluate mental illness and its progression, with powerful visualization. This web-based diagnostic platform has international multicenter validation, scientific publication, patent-pending as well as awarded by the 17th National Innovation Award in 2020, etc. This evidence-based, AI-assisted psychiatric diagnosis platform, validated with large-scale standardized brain imaging. We believe this state-of-the-art diagnostic tool can be a new light on modern psychiatric medicine, and promote mental health in the general population.
-
An intelligent decision support system: prediction of hospitalization and length of stay, and similar medical records retrieval for proper patients arrangement in an emergency department.
The core concept of the decision support system is to establish machine learning-based predictive models and enable their interpretability to support physicians making clinical decisions in practice.